Diplomat Specialty Pharmacy Health Services Division Achieves High Marks in Pilot Program for Chronic Kidney Disease Management
Posted on: Wednesday, 17 October 2007, 18:00 CDT
SWARTZ CREEK, Mich., Oct. 17 /PRNewswire/ -- Diplomat Health Services, in conjunction with McLaren Health Plan, The National Kidney Foundation of Michigan, and corporate sponsor Genzyme, announced today the results of its pilot program for the management of Chronic Kidney Disease (CKD). The program managed chronic kidney disease patients for McLaren Health Plan and showed combined medication and medical cost savings of $300 per patient per month compared to the control group.
Ron Alexander, Vice President of Clinical Services, stated, "This proactive approach proves the effectiveness of our Disease Management Program. We further validated the published savings of $150 per patient per day in delaying the onset of dialysis. Kudos to our staff who received excellent results from our patient satisfaction surveys. Obviously we are very pleased with these results."
The program developed over the course of one year included disease management for Chronic Kidney Disease, Diabetes, and Hypertension. The heart of the CKD Navigator Program is Diplomat's clinical staff who consulted with the patient and their primary care physician to assist in the care of the patient. Medical and prescription cost data was tracked for 6 months and compared to a control group. The program will now be expanded to include additional patients.
Dr. Petroff, Medical Director, McLaren Health Plan stated, "We know disease management programs benefit both patients and healthcare professionals. The results of this CKD pilot program prove that a well-managed CKD disease management program can make a difference in the health of people living with this disease. This data proves that when patients are personally coached or managed, they become more adherent in taking their medication and have a more positive response to therapy."
Maurie Ferriter, Director of Programs and Services at the National Kidney Foundation of Michigan stated, "This shows that this is truly a win - win situation for patients and providers. Providers save money in the management of people with CKD and the individuals with CKD have a better medical outcome and quality of life."
About Diplomat Specialty Pharmacy
Diplomat Specialty Pharmacy is a privately held health care organization focusing on complete medication management programs for patients with serious and chronic conditions. Key programs include: Oncology, HIV/AIDS, Hepatitis C, Multiple Sclerosis, Rheumatoid Arthritis and Psoriasis. Other specialty areas include Transplant, Fertility, Dialysis Medication Management, Bio- Identical Hormone Replacement Therapy and Specialty Compounding. The company's Health Services division specializes in Disease Management programs for Chronic Kidney Disease patients, as well as Home Infusion and operates infusion suites. "With locations in Flint and Grand Rapids, MI; Cleveland, OH; Chicago, IL; and Ft. Lauderdale, FL; Diplomat services the specialty pharmacy needs of patients and physicians nationwide."
For more information contact: Alecia Greilich - Director of Payor Relations agreilich@diplomatpharmacy.com 810-720-4451
Diplomat Specialty Pharmacy
CONTACT: Alecia Greilich - Director of Payor Relations of DiplomatSpecialty Pharmacy, +1-810-720-4451, agreilich@diplomatpharmacy.com
Web site: http://www.diplomatpharmacy.com/
Source: PRNewswire
Related Articles
- Silverlink Strengthens Health and Disease Management Programs With the Industry's Most Automated Call Solutions and Extensive Services
- Tufts Health Plan Expands Disease Management Program With Alere Medical to Include COPD Patients and Frail Elderly
- Aetna Behavioral Health Introduces Industry-First Bipolar Disease Management Program
- Disease Management Programs Can Help Improve the Health of Medicaid Patients Through Improved Care Coordination While Helping To Control Medicaid Costs
- Patient Adherence and Disease Management Programs Must Win Patient Buy-In for Success
- Optimize the Effectiveness of Pharma Patient Adherence and Disease Management Programs With Market Research
- Alere Expands Disease Management Program With Humana to Include Medicare Patients With Chronic Obstructive Pulmonary Disease
- See the Impact Disease Management Programs Can Have on Improving the Health Status of Medicaid Beneficiaries
- First German Disease Management Program for Breast Cancer
- Soarian Disease Management Helps Improve Care of Congestive Heart Failure Patients; Siemens Announces General Availability of Latest Healthcare IT Innovation
 |
 |
User Comments (0)
RSS Feeds